http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4852100-B2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 2006-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-4852100-B2 |
| titleOfInvention | Use of N- (dibenzo (b, f) oxepin-10-ylmethyl) -N-methyl-N-prop-2-ynylamine (omigapil) for the prevention and / or treatment of muscular dystrophy |
| priorityDate | 2005-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 399.